N/A
N=200
Moxibustion in a Randomized Trial for Version of Breech Position From Week 32
Presentation; Breech, With External Version Before Labor
Bottom Line
View on ClinicalTrials.gov: NCT02251886 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Number of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment — 34; 25; 34; 25 participants — p=0.48
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Moxibustion in primiparae (Other); Moxibustion in multiparae (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Herning Hospital
- Primary completion
- Jan 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Version of Fetal Breech Position to Cephalic Position up to 4 Weeks After Treatment |
34; 25; 34; 25 | 0.48 |
Summary
Moxibustion was tested for version of a breech position in singleton pregnancies. The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study.
Eligibility Criteria
Inclusion Criteria
- pregnant women with singleton breech position of their babies
Exclusion Criteria
- vaginal bleeding in 2nd and 3rd trimester, placental insufficiency, cervical shortening, premature rupture of membranes, preeclampsia, high blood pressure, pelvic insufficiency, low placental position, placenta praevia, uterine malformations, previous corrective uterine surgery, known fetal morbidity
Data sourced from ClinicalTrials.gov (NCT02251886). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.